by Carney MW, Department of Psychiatry, Northwick Park Hospital and Clinical Research Centre, Harrow, Middlesex, England. Clin Neuropharmacol 1988 Apr; 11(2):183-8
Five female patients who developed psychosis while taking diethylpropion hydrochloride are described, four with paranoid psychosis and one with manic psychosis. In all but one patient, these drugs were medically prescribed. Although relatively few cases of psychosis and psychosis-like illness were reported to the Committee for Safety of Medicines from 1963 until 1986, further cases may be anticipated. Patients on the drug should be carefully supervised and it should not be prescribed to those with personality disorder, previous evidence of amphetamine, alcohol, or other drug abuse, or those with a history of psychiatric breakdown.
For those seeking addiction treatment for themselves or a loved one, the Amphetamines.com helpline is a private and convenient solution.
Calls to any general helpline (non-facility specific 1-8XX numbers) for your visit will be answered by American Addiction Centers (AAC), a paid advertiser on Amphetamines.com.
AAC representatives are standing by 24/7 to discuss your treatment options. These representatives work solely for AAC and will discuss whether an AAC facility may be an option for you. This helpline is offered at no cost to you and with no obligation to enter into treatment. Neither Amphetamines.com nor AAC receives any commission or other fee that is dependent upon which treatment provider a visitor may ultimately choose.
For more information on AAC’s commitment to ethical marketing and treatment practices, or to learn more about how to select a treatment provider, visit AmericanAddictionCenters.org. If you wish to explore additional treatment options or connect with a specific rehab center, you can browse top-rated listings or visit SAMHSA.